Spots Global Cancer Trial Database for double cord blood transplant
Every month we try and update this database with for double cord blood transplant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Randomized Double Cord Blood Transplant Study | NCT00067002 | Leukemia, Lymph... Leukemia, Myelo... Leukemia, Myelo... Lymphoma, Non-H... | Expanded alloge... One Unmanipulat... Rituxan Melphalan Thiotepa Fludarabine Cyclophosphamid... Mesna Total body irra... | 1 Month - 80 Years | M.D. Anderson Cancer Center | |
TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation | NCT01300611 | Double Cord Blo... Acute Myelogeno... Myelodysplastic... Myelofibrosis Acute Lymphobla... Chronic Myelocy... Non Hodgkins Ly... Hodgkins Lympho... Chronic Lymphoc... | TXA127 300 mcg/... TXA127 1000 mcg... | 18 Years - 60 Years | Tarix Pharmaceuticals | |
TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation | NCT01300611 | Double Cord Blo... Acute Myelogeno... Myelodysplastic... Myelofibrosis Acute Lymphobla... Chronic Myelocy... Non Hodgkins Ly... Hodgkins Lympho... Chronic Lymphoc... | TXA127 300 mcg/... TXA127 1000 mcg... | 18 Years - 60 Years | Tarix Pharmaceuticals |